Halozyme Therapeutics Inc (HALO)
37.83
-0.19
(-0.50%)
USD |
NASDAQ |
Apr 18, 16:00
37.83
0.00 (0.00%)
After-Hours: 20:00
Halozyme Therapeutics Profit Margin (Quarterly): 37.12% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 37.12% |
| September 30, 2023 | 37.88% |
| June 30, 2023 | 33.82% |
| March 31, 2023 | 24.43% |
| December 31, 2022 | 31.79% |
| September 30, 2022 | 29.49% |
| June 30, 2022 | 14.89% |
| March 31, 2022 | 51.25% |
| December 31, 2021 | 65.46% |
| September 30, 2021 | |
| June 30, 2021 | 67.02% |
| March 31, 2021 | 31.34% |
| December 31, 2020 | 60.12% |
| September 30, 2020 | 55.43% |
| June 30, 2020 | 46.75% |
| March 31, 2020 | -24.07% |
| December 31, 2019 | -64.10% |
| September 30, 2019 | -54.11% |
| June 30, 2019 | -37.36% |
| March 31, 2019 | 3.15% |
| December 31, 2018 | -3.53% |
| September 30, 2018 | -109.0% |
| June 30, 2018 | -65.03% |
| March 31, 2018 | -88.95% |
| December 31, 2017 | 65.35% |
| Date | Value |
|---|---|
| September 30, 2017 | 4.31% |
| June 30, 2017 | -91.15% |
| March 31, 2017 | -111.3% |
| December 31, 2016 | -70.22% |
| September 30, 2016 | -90.87% |
| June 30, 2016 | -80.62% |
| March 31, 2016 | -46.63% |
| December 31, 2015 | 8.27% |
| September 30, 2015 | -117.7% |
| June 30, 2015 | 6.96% |
| March 31, 2015 | -80.94% |
| December 31, 2014 | -17.36% |
| September 30, 2014 | -138.8% |
| June 30, 2014 | -88.51% |
| March 31, 2014 | -221.9% |
| December 31, 2013 | -175.9% |
| September 30, 2013 | -120.5% |
| June 30, 2013 | -158.5% |
| March 31, 2013 | -163.0% |
| December 31, 2012 | -20.22% |
| September 30, 2012 | -375.0% |
| June 30, 2012 | -180.8% |
| March 31, 2012 | -203.2% |
| December 31, 2011 | -763.8% |
| September 30, 2011 | 22.51% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-64.10%
Minimum
Dec 2019
67.02%
Maximum
Jun 2021
22.62%
Average
32.81%
Median
Profit Margin (Quarterly) Benchmarks
| Johnson & Johnson | 18.92% |
| Globus Medical Inc | 2.44% |
| Denali Therapeutics Inc | -- |
| AIM ImmunoTech Inc | -19.35K% |
| Protalix BioTherapeutics Inc | -57.64% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 195.6% |
| Return on Assets | 15.68% |
| Return on Invested Capital | 17.14% |
| Gross Profit Margin (Quarterly) | 77.27% |
| Operating Margin (Quarterly) | 43.92% |
| Return on Net Operating Assets | 20.57% |